SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Balcer, L. J
Right arrow Articles by Maguire, M. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balcer, L. J
Right arrow Articles by Maguire, M. G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis

Laura J Balcer

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Monika L Baier

Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA

Victoria S Pelak

Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado, USA

Robert J Fox

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Sarah Shuwairi

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Steven L Galetta

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Gary R Cutter

Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA

Maureen G Maguire

Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

The quantitative assessment of visual function in multiple sclerosis (MS) clinical trials has been limited to Snellen visual acuity. The purpose of this study was to examine the inter-rater reliability and test characteristics of a new visual outcome measure, the Low-Contrast Sloan Letter Charts, in patients with MS and visually-asymptomatic volunteers. Contrast letter acuity scores (letter scores) were measured at each of four contrast levels (100, 5, 1.25 and 0.6%) by two independent raters. Inter-rater agreement was described with the intraclass correlation coefficient (ICC) and comparison of mean scores. Excellent inter-rater agreement (ICC=0.86-0.95) was demonstrated at each contrast level among MS patients (n=100) and visually-asymptomatic volunteers (n=33). Average letter scores at the lowest contrast level (0.6%) were highly variable in the MS group, even among patients with visual acuities of 20/20 or better, and among those who required no assistance for ambulation. Low-Contrast Sloan Letter Chart testing is a highly reliable method of visual assessment, and provides information on an aspect of neurologic impairment in MS which is not captured by Snellen visual acuity or ambulation status. This new method demonstrates excellent potential as a visual function outcome measure for future MS clinical trials.

Key Words: vision • contrast letter acuity • multiple sclerosis • MS • reliability • outcome measures

Multiple Sclerosis, Vol. 6, No. 3, 163-171 (2000)
DOI: 10.1177/135245850000600305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
M. J. Thurtell, E. Bala, S. S. Yaniglos, J. C. Rucker, N. S. Peachey, and R. J. Leigh
Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials
Neurology, December 1, 2009; 73(22): 1849 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E M Mowry, M J Loguidice, A B Daniels, D A Jacobs, C E Markowitz, S L Galetta, M L Nano-Schiavi, G R Cutter, M G Maguire, and L J Balcer
Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity
J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. T. Naismith, N. T. Tutlam, J. Xu, E. C. Klawiter, J. Shepherd, K. Trinkaus, S. K. Song, and A. H. Cross
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis
Neurology, March 24, 2009; 72(12): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. M. Frohman, F. Costello, O. Stuve, P. Calabresi, D. H. Miller, S. J. Hickman, R. Sergott, A. Conger, A. Salter, K. H. Krumwiede, et al.
Modeling Axonal Degeneration Within the Anterior Visual System: Implications for Demonstrating Neuroprotection in Multiple Sclerosis
Arch Neurol, January 1, 2008; 65(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. P. D. Henderson, S. A. Trip, P. G. Schlottmann, D. R. Altmann, D. F. Garway-Heath, G. T. Plant, and D. H. Miller
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography
Brain, January 1, 2008; 131(1): 277 - 287.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. F. Wu, E. D. Schwartz, T. Lei, A. Souza, S. Mishra, D. A. Jacobs, C. E. Markowitz, S. L. Galetta, M. L. Nano-Schiavi, L. M. Desiderio, et al.
Relation of vision to global and regional brain MRI in multiple sclerosis
Neurology, December 4, 2007; 69(23): 2128 - 2135.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis, November 1, 2007; 13(9): 1176 - 1182.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
L. Leocani, E. Comi, P. Annovazzi, M. Rovaris, P. Rossi, M. Cursi, M. Comola, V. Martinelli, and G. Comi
Impaired Short-term Motor Learning in Multiple Sclerosis: Evidence From Virtual Reality
Neurorehabil Neural Repair, May 1, 2007; 21(3): 273 - 278.
[Abstract] [PDF]


Home page
NeurologyHome page
L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, et al.
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Neurology, April 17, 2007; 68(16): 1299 - 1304.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. R. Lynch, J. M. Farmer, A. Y. Tsou, S. Perlman, S. H. Subramony, C. M. Gomez, T. Ashizawa, G. R. Wilmot, R. B. Wilson, and L. J. Balcer
Measuring Friedreich ataxia: Complementary features of examination and performance measures
Neurology, June 13, 2006; 66(11): 1711 - 1716.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Iliceto, and C. Sborgia
Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1264 - 1268.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. L. Baier, G. R. Cutter, R. A. Rudick, D. Miller, J. A. Cohen, B. Weinstock-Guttman, M. Mass, and L. J. Balcer
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
Neurology, March 22, 2005; 64(6): 992 - 995.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. J. Balcer, M. L. Baier, J. A. Cohen, M. F. Kooijmans, A. W. Sandrock, M. L. Nano-Schiavi, D. C. Pfohl, M. Mills, J. Bowen, C. Ford, et al.
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
Neurology, November 25, 2003; 61(10): 1367 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R A Rudick, G Cutter, and S Reingold
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials
Multiple Sclerosis, October 1, 2002; 8(5): 359 - 365.
[Abstract] [PDF]



Advertisement